Galectin Therapeutics Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 14/08/2026 | Mar 2026Filed 15/05/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 14/08/2026 | Mar 2025Filed 15/05/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/08/2025 | Mar 2024Filed 15/05/2025 |
|---|---|---|---|---|---|---|---|---|
| −$9.1 | −$5 | −$8.2 | −$7.5 | −$9.6 | −$11 | −$12 | −$11 | |
| −$0.14 | −$0.08 | −$0.13 | −$0.12 | −$0.15 | −$0.18 | −$0.20 | −$0.19 | |
| 66 | 66 | 64 | 63 | 63 | 62 | 62 | 62 |
Trend